Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development

With the development of modern next generation sequencing based DNA diagnostic methods, it has become possible to study hereditary predisposition to oncohematological diseases. Germline variants (mutations) of RUNX1, CEBPA, GATA2, ANKRD26, DDX41, FANC- (Fanconi anemia), etc. genes, associated with t...

Full description

Saved in:
Bibliographic Details
Main Authors: M. V. Makarova, M. V. Nemtsova, D. A. Chekini, D. K. Chernevskiy, O. V. Sagaydak, E. V. Kosova, A. A. Krinitsyna, M. S. Belenikin, P. A. Zeynalova
Format: Article
Language:Russian
Published: ABV-press 2024-04-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/918
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849409337195233280
author M. V. Makarova
M. V. Nemtsova
D. A. Chekini
D. K. Chernevskiy
O. V. Sagaydak
E. V. Kosova
A. A. Krinitsyna
M. S. Belenikin
P. A. Zeynalova
author_facet M. V. Makarova
M. V. Nemtsova
D. A. Chekini
D. K. Chernevskiy
O. V. Sagaydak
E. V. Kosova
A. A. Krinitsyna
M. S. Belenikin
P. A. Zeynalova
author_sort M. V. Makarova
collection DOAJ
description With the development of modern next generation sequencing based DNA diagnostic methods, it has become possible to study hereditary predisposition to oncohematological diseases. Germline variants (mutations) of RUNX1, CEBPA, GATA2, ANKRD26, DDX41, FANC- (Fanconi anemia), etc. genes, associated with the development of hereditary hematological malignancies, have been identified. Timely diagnosis of such diseases will allow for medical genetic counseling and testing of the patient’s relatives to identify or exclude the risk of developing the disease, select a donor for the patient (it is undesirable to use a mutation carrier relative as a donor), and personalize the choice of chemotherapy regimens (for example, patients with Fanconi anemia may experience increased sensitivity to chemotherapy). The aim of this review is to present a modern view of the genetic predisposition to the development of hematological malignancies.
format Article
id doaj-art-bd8f7088c9b34c6bb83ecf465f6aa063
institution Kabale University
issn 1818-8346
2413-4023
language Russian
publishDate 2024-04-01
publisher ABV-press
record_format Article
series Онкогематология
spelling doaj-art-bd8f7088c9b34c6bb83ecf465f6aa0632025-08-20T03:35:32ZrusABV-pressОнкогематология1818-83462413-40232024-04-011928810010.17650/1818-8346-2024-19-2-88-100754Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of developmentM. V. Makarova0M. V. Nemtsova1D. A. Chekini2D. K. Chernevskiy3O. V. Sagaydak4E. V. Kosova5A. A. Krinitsyna6M. S. Belenikin7P. A. Zeynalova8EVOGEN; Russian Scientific Center of Roentgenoradiology, Ministry of Health of RussiaEVOGEN; Research Centre for Medical Genetics; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia (Sechenov University)Clinical Hospital “Lapino” of the “Mother and Child” Group of companiesEVOGEN; Privolzhsky Research Medical University, Ministry of Health of RussiaEVOGEN; National Medical Research Centre of Cardiology named after Academician E.I. Chazov, Ministry of Health of RussiaEVOGENEVOGENEVOGENClinical Hospital “Lapino” of the “Mother and Child” Group of companiesWith the development of modern next generation sequencing based DNA diagnostic methods, it has become possible to study hereditary predisposition to oncohematological diseases. Germline variants (mutations) of RUNX1, CEBPA, GATA2, ANKRD26, DDX41, FANC- (Fanconi anemia), etc. genes, associated with the development of hereditary hematological malignancies, have been identified. Timely diagnosis of such diseases will allow for medical genetic counseling and testing of the patient’s relatives to identify or exclude the risk of developing the disease, select a donor for the patient (it is undesirable to use a mutation carrier relative as a donor), and personalize the choice of chemotherapy regimens (for example, patients with Fanconi anemia may experience increased sensitivity to chemotherapy). The aim of this review is to present a modern view of the genetic predisposition to the development of hematological malignancies.https://oncohematology.abvpress.ru/ongm/article/view/918hereditary cancer syndromeshematological malignanciesnext generation sequencing
spellingShingle M. V. Makarova
M. V. Nemtsova
D. A. Chekini
D. K. Chernevskiy
O. V. Sagaydak
E. V. Kosova
A. A. Krinitsyna
M. S. Belenikin
P. A. Zeynalova
Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development
Онкогематология
hereditary cancer syndromes
hematological malignancies
next generation sequencing
title Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development
title_full Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development
title_fullStr Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development
title_full_unstemmed Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development
title_short Hereditary predisposition syndromes to myeloid neoplasms: diseases, genes and mechanisms of development
title_sort hereditary predisposition syndromes to myeloid neoplasms diseases genes and mechanisms of development
topic hereditary cancer syndromes
hematological malignancies
next generation sequencing
url https://oncohematology.abvpress.ru/ongm/article/view/918
work_keys_str_mv AT mvmakarova hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment
AT mvnemtsova hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment
AT dachekini hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment
AT dkchernevskiy hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment
AT ovsagaydak hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment
AT evkosova hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment
AT aakrinitsyna hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment
AT msbelenikin hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment
AT pazeynalova hereditarypredispositionsyndromestomyeloidneoplasmsdiseasesgenesandmechanismsofdevelopment